AliveCor QT Service vs ZEUS System (Zio Watch)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by iRhythm Technologies

AI Verdict

Tool A is designed for instant QT/QTc interval measurement to assess cardiac safety, particularly for medication prescribing. Tool B, conversely, provides long-term continuous cardiac monitoring via a wearable device to detect and characterize atrial fibrillation and other arrhythmias. While both utilize AI in cardiology, their distinct focus on specific cardiac parameters and monitoring durations makes them adjacent rather than direct competitors.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if you are a healthcare professional requiring immediate and precise QT/QTc interval measurements from AliveCor 6-Lead ECGs. This tool is ideal for rapidly assessing cardiac safety, particularly when making critical medication prescribing decisions or monitoring patients on QT-prolonging drugs.

View AliveCor QT Service →

Choose ZEUS System (Zio Watch) if…

Choose ZEUS System (Zio Watch) if you need long-term continuous cardiac monitoring to detect and characterize intermittent arrhythmias such as Atrial Fibrillation. This wearable solution is best suited for identifying and quantifying arrhythmia burden over an extended period (up to 14 days), providing comprehensive data for diagnosis and management of elusive cardiac conditions.

View ZEUS System (Zio Watch) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AliveCor QT Service ZEUS System (Zio Watch)
Pricing Varies by product and service, with subscription options available. Contact vendor
Deployment Mobile app, cloud-based platform, EHR integration. Cloud-based system with a wearable device
BAA Available Yes AI-estimated Unknown
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System (Zio Watch)

Tool B offers a comprehensive and integrated user experience for both patients and healthcare professionals, featuring a dedicated wearable for continuous monitoring and a patient app for engagement and symptom logging. While Tool A leverages user-friendly devices, Tool B's end-to-end service with its wearable and patient app provides a broader and potentially more seamless patient journey, emphasizing patient simplicity and compliance for long-term wear.

Clinical Value

ZEUS System (Zio Watch)

While Tool A provides critical, specialized cardiac safety measurements (QT/QTc intervals) vital for medication management, Tool B offers broader, long-term continuous cardiac monitoring for a wider range of arrhythmias, including Atrial Fibrillation (AFib), over extended periods (up to 14 days). Tool B also boasts clinically actionable reports with high physician agreement (99%), suggesting a more comprehensive diagnostic clinical value.

Pricing & Value

Tie

Both tools explicitly state that pricing information is available only by contacting the vendor. Without specific pricing details or further information on their value propositions, it is impossible to conduct a meaningful comparison or determine a winner in this dimension.

Enterprise Readiness

ZEUS System (Zio Watch)

Both tools are HIPAA compliant and offer BAAs, which are foundational for enterprise use. However, Tool B demonstrates a more extensive and mature enterprise integration strategy with explicit mention of HL7 integration, compatibility with over 350 major EHR systems, integration with the Epic Aura network, and a dedicated EHR integration team, indicating a higher level of readiness for complex healthcare environments.

Innovation

ZEUS System (Zio Watch)

Both tools leverage AI, but Tool B's innovation lies in its combination of a novel AI-powered wearable biosensor (Zio Watch) for continuous, long-term multi-modal data collection (ECG and PPG) and its comprehensive AI-powered arrhythmia detection over extended periods. This approach pushes the boundaries of remote cardiac diagnostics more broadly than Tool A's specialized instant QT/QTc measurement from a portable ECG device.

Support & Docs

ZEUS System (Zio Watch)

Both products offer substantial documentation, including instructions for use and educational materials. However, Tool B's explicit mention of a dedicated EHR integration team, alongside comprehensive patient and provider support resources such as FAQs and patient education, suggests a more robust and specialized support structure, particularly beneficial for enterprise clients and complex integrations.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AliveCor QT Service ZEUS System (Zio Watch)
Name AliveCor QT Service ZEUS System (Zio Watch)
Company AliveCor iRhythm Technologies
Primary Function Provides instant, accurate QT and QTc interval measurements for cardiac safety assessment and medication prescribing decisions. Detects and characterizes Atrial Fibrillation (AFib) and other cardiac arrhythmias.
Data Source / Device Type Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L) Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection
Monitoring Duration Not specified Long-term continuous monitoring for up to 14 days
Target User / Prescription Prescription (Rx) use only, for qualified healthcare professionals Provides actionable insights for physicians

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and ZEUS System (Zio Watch).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AliveCor QT Service is designed for instant, accurate QT and QTc interval measurements to assess cardiac safety and inform medication prescribing decisions. The ZEUS System (Zio Watch) is for long-term continuous cardiac monitoring to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for physicians.
AliveCor QT Service analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices, providing instant measurements. In contrast, the ZEUS System (Zio Watch) utilizes a wearable biosensor (Zio Watch) for continuous ECG and PPG data collection over an extended period, up to 14 days.
AliveCor QT Service provides instant, accurate QT and QTc interval measurements using Bazett's and Fridericia's formulas. The ZEUS System (Zio Watch) offers advanced arrhythmia detection and analysis, specifically characterizing Atrial Fibrillation (AFib) burden.
AliveCor QT Service analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices, such as the KardiaMobile 6L. The ZEUS System (Zio Watch) uses the Zio Watch wearable biosensor for continuous ECG and PPG data collection.
AliveCor QT Service provides instant QT measurements from individual ECGs. The ZEUS System (Zio Watch) offers long-term continuous monitoring for up to 14 days.
AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. The ZEUS System (Zio Watch) utilizes the ZioSuite portal and a provider mobile app for report interpretation and patient management, complemented by a MyZio patient app.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.